Production (Stage)
Exact Sciences Corporation
EXAS
$56.95
$0.470.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.93% | 0.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.93% | 0.67% | |||
| Cost of Revenue | -27.41% | 44.91% | |||
| Gross Profit | 16.60% | -16.25% | |||
| SG&A Expenses | 7.73% | 8.85% | |||
| Depreciation & Amortization | -- | -390.80% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.38% | 3.86% | |||
| Operating Income | -95.03% | -125.87% | |||
| Income Before Tax | 88.47% | -2,240.40% | |||
| Income Tax Expenses | 101.97% | -1,508.54% | |||
| Earnings from Continuing Operations | 88.29% | -2,161.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 88.29% | -2,161.18% | |||
| EBIT | -95.03% | -125.87% | |||
| EBITDA | -341.02% | -68.65% | |||
| EPS Basic | 88.39% | -2,155.00% | |||
| Normalized Basic EPS | -107.16% | -149.73% | |||
| EPS Diluted | 88.41% | -2,125.48% | |||
| Normalized Diluted EPS | -107.16% | -149.73% | |||
| Average Basic Shares Outstanding | 0.81% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.81% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||